Acknowledgements This work was supported by grants from the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (CIFMS, grant no
According to a recent study, the STEP 1 trial in 2021, a subset of 140 patients underwent gold-standard DEXA scans to track body composition before and after their GLP-1 treatment
That is the time to be deliberate about replacing it
Key Summary The patent for semaglutide will expire in 10 countries this year, but the UK patent will remain till 2031
Post-Surgical Recovery: Peptides can accelerate tissue integration, reduce post-operative inflammation, and minimize scar tissue formation following joint replacements, ligament reconstructions, or soft tissue repairs
None of this means GLP-1 drugs are the wrong choice